SCHEMBL2082296

SCHEMBL2082296

COC(=O)c1cc(F)c(NN)cc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.43
GAA P10253 4/20 0.39
ALDH1A1 P00352 4/20 0.39
ILK Q13418 1/20 0.39
ROCK2 O75116 1/20 0.39
HSD17B10 Q99714 3/20 0.39
MAPT P10636 3/20 0.39
ATM Q13315 2/20 0.39
HPGD P15428 2/20 0.39
GLA P06280 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
CFTR P13569 3/20 0.38
ABL1 P00519 1/20 0.38
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA7 P43166 2/20 0.37
CA9 Q16790 2/20 0.37
CA14 Q9ULX7 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL522786 0.84 CA12 (0.47) KDM4EGAAALDH1A1HSD17B10MAPT
SCHEMBL410165 0.81 ALPL (0.45) KDM4EGAAALDH1A1HSD17B10MAPT
Hydrochloric Acid SCHEMBL1787107 0.80 GAA (0.46) KDM4EGAAALDH1A1MAPTHPGD
SCHEMBL2081121 0.79 ROCK2 (0.41) KDM4EGAAALDH1A1ROCK2MAPT
SCHEMBL2080318 0.78 KDM4E (0.50) KDM4EGAAALDH1A1ILKHSD17B10
SCHEMBL29813036 0.78 KDM4E (0.50) KDM4EGAAALDH1A1ILKHSD17B10
SCHEMBL2900514 0.78 KDM4E (0.59) KDM4EGAAALDH1A1ILKHSD17B10
SCHEMBL23970830 0.78 KDM4E (0.52) KDM4EGAAALDH1A1HSD17B10MAPT
Hydrochloric Acid SCHEMBL3657255 0.77 GAA (0.43) KDM4EGAAALDH1A1MAPTHPGD
SCHEMBL13839229 0.76 KDM4E (0.50) KDM4EGAAALDH1A1HSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2007773-B1 THIAZOLYL DIHYDRO-INDAZOLES BOEHRINGER INGELHEIM INT (DE) 2012-10-24 EP disclosed
US-7902183-B2 Thiazolyl-dihydro-indazole BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-03-08 US disclosed
US-7902183-B2 Thiazolyl-dihydro-indazole BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-03-08 US disclosed
US-7902183-B2 Thiazolyl-dihydro-indazole BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-03-08 US disclosed
US-20070270401-A1 Thiazolyl-Dihydro-Indazole BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-11-22 US disclosed
US-20070270401-A1 Thiazolyl-Dihydro-Indazole BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-11-22 US disclosed
US-20070270401-A1 Thiazolyl-Dihydro-Indazole BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-11-22 US disclosed
WO-2007113245-A1 THIAZOLYL DIHYDRO-INDAZOLES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270401-A1 Thiazolyl-Dihydro-Indazole MKI67, INSR, CCNT1 KDM4E 3502/4885GAA 1130/4885ALDH1A1 44/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.